Disease-modifying effects of MCP-1 alleles in a cohort of infected European- and African-American adults or in a cohort of Argentinean children with perinatally acquired HIV-1. (a and b) KM curves of the development of AIDS or death in the entire European-American portion of the adult cohort that are wild type (blue), heterozygous (black), or homozygous (red) for the MCP-1 –2578G allele. P and relative hazard (RH) (95% CI) indicate the significance value by log-rank test and the relative hazard with respect to the reference group (−2578A/A), respectively. (c) KM curves of the development of AIDS in infected Argentinean children that are wild type (blue), heterozygous (black), or homozygous (red) for the –2578G allele. P and RH (95% CI) indicate the significance value by log-rank test and the RH with respect to the reference group (−2578A/A), respectively. (d and e) KM curves of the development of AIDS or death in the entire European-American portion of the adult cohort that possess (blue) or lack (red) the ancestral MCP-1 AA haplotype. The reference group consists of individuals who possess the ancestral AA haplotype. (f and g) KM curves comparing the clinical course in European-Americans with the following haplotype pairs: AA/AA, the reference group (blue) and GA/GA (red). Compared with the reference group, there was no difference in progression to AIDS or death for individuals who had the AA/GA, GA/AT, AA/AT or AT/AT haplotype pairs. For illustrative purposes, we therefore combined the data for AA/GA and AT/GA (black), and AA/AT and AT/AT (green). (h and i) KM curves comparing the clinical course of infected African-Americans who possess the following haplotype pairs: AA/AA, the reference group (blue); AA/AT (green); and AA/GA (red). The reference groups for the survival analyses in f–i consist of individuals of the indicated population that are homozygous for MCP-1 haplotype AA (blue). Note that the red- and green-colored KM curves in f, g and h, i are for individuals with different haplotype pairs. (j) Risk of developing HAD in individuals who possess the MCP-1 GA/GA haplotype pair compared with those who have the ancestral haplotype pair AA/AA. (k) Risk of developing HAD, MAC infection, PCP, cytomegalovirus (CMV) infection, or Kaposi's sarcoma (KS) in individuals who possess the GA/GA haplotype pair. Closed circles and crosses denote the OR and boundaries of the 95% CI limits, respectively. NS, not significant. (l) The KM curves of the development of HAD, MAC, and PCP in European-Americans that possess the following haplotype pairs: AA/AA, the reference group (blue); GA/GA (red); and combined analyses for the other four MCP-1 haplotype pairs (green). The rate per 1,000 person-years of HAD was 9.0; of MAC infection, 15.4; of PCP, 32.8; of CMV infection, 16.7; and of Kaposi's sarcoma, 12.4.